Aldeyra Therapeutics (ALDX) Prices 10M Share IPO at $12.50/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Aldeyra Therapeutics (ALDX) Announces Proposed $125 Million Public Offering of Common Stock
April 27, 2021 4:08 PM EDTAldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with immune-mediated diseases, today announced that it intends to offer and sell, subject to market and other... More
Aldeyra Therapeutics (ALDX) PT Raised to $16 at Oppenheimer, Following Clinical Update
April 27, 2021 3:29 PM EDTOppenheimer analyst Yichuan (Jackie) Yan raised the price target on Aldeyra Therapeutics (NASDAQ: ALDX) to $16.00 (from $15.00) while maintaining a Outperform rating.
... MorePre-Open Movers 04/27: (FCBP) (GMBL) (ALDX) Higher; (RNWK) (AGTC) (HYFM) Lower (more...)
April 27, 2021 9:27 AM EDTPre-Open Stock Movers:
First Choice Bancorp (Nasdaq: FCBP) 24.3% HIGHER; Enterprise Financial Services Corp (Nasdaq: EFSC) and First Choice Bancorp (Nasdaq: FCBP) announced today that EFSC, EB&T, FCBP and First Choice have entered into a definitive merger agreement pursuant to which EFSC will acquire, in an all-stock merger, FCBP.
RealNetworks, Inc. (NASDAQ: RNWK) 19% LOWER; commenced a proposed underwritten public offering of its common stock pursuant to RealNetworks' shelf registration... More
Aldeyra Therapeutics (ALDX) to Resume Trading at 7:30 a.m.
April 27, 2021 7:16 AM EDTAldeyra Therapeutics (NASDAQ: ALDX) to Resume Trading at 7:30 a.m.
Aldeyra Therapeutics (ALDX) Achieves Statistical Significance for Primary Endpoint and All Secondary Endpoints in Phase 3 INVIGORATE Clinical Trial of Reproxalap in Allergic Conjunctivitis
April 27, 2021 7:03 AM EDTAldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the... More
Aldeyra Therapeutics (ALDX) Halted for News
April 27, 2021 7:02 AM EDTAldeyra Therapeutics (NASDAQ: ALDX) Halted for News
... More